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Abstract: Mesenchymal stem cells (MSCs) are commonly isolated from bone marrow and adipose
tissue. Depending on the tissue of origin, MSCs have different characteristics and physiological effects.
In various cancer studies, MSCs have been found to have either tumor-promoting or tumor-inhibiting
action. This study investigated the effect of adipose tissue-MSCs (AT-MSCs) and bone marrow-MSCs
(BM-MSCs) on global long interspersed nuclear element-1 (LINE-1) methylation, the expression
level of microenvironment remodeling genes and cell proliferation, migration and invasion of oral
tongue squamous cell carcinoma (OTSCC). Additionally, we studied the effect of human tongue
squamous carcinoma (HSC-3)-conditioned media on LINE-1 methylation and the expression of
microenvironment remodeling genes in AT-MSCs and BM-MSCs. Conditioned media from HSC-3 or
MSCs did not affect LINE-1 methylation level in either cancer cells or MSCs, respectively. In HSC-3
cells, no effect of MSCs-conditioned media was detected on the expression of ICAM1, ITGA3 or
MMP1. On the other hand, HSC-3-conditioned media upregulated ICAM1 and MMP1 expression in
both types of MSCs. Co-cultures of AT-MSCs with HSC-3 did not induce proliferation, migration or
invasion of the cancer cells. In conclusion, AT-MSCs, unlike BM-MSCs, seem not to participate in oral
cancer progression.
Keywords: mesenchymal stem cells; adipose tissue; bone marrow; oral squamous cell carcinoma;
invasion; migration
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1. Introduction
Mesenchymal stem cells (MSCs) comprise a heterogeneous source of adherent cells that express
specific surface markers, e.g., CD73, CD90 and CD105, and have the capacity for multilineage
differentiation [1]. MSCs release various cytokines and growth factors that, through paracrine signaling,
modulate a range of acute and chronic pathological conditions [2,3]. Though MSCs are present in
all organs of the body, they are commonly isolated from the bone marrow or adipose tissue. Bone
marrow-derived MSCs (BM-MSCs) were the first MSCs to be discovered and to date are also the most
studied in terms of characterization and clinical applications [4]. However, adipose tissue-derived
MSCs (AT-MSCs) offer the operational advantages of easier and safer isolation procedures, collection
of larger volume of tissue material and higher proliferative capacity [1,5]. BM-MSCs and AT-MSCs
have several differences in their characteristics, functions and clinical applications, despite sharing a
few similarities [6,7].
In recent decades, the role of MSCs in cancer has generated interest and several studies have
been carried out to that end, but the results have been controversial. Some studies attribute both
AT-MSCs and BM-MSCs to promoting tumor progression and metastasis [6,8,9]. Cells co-expressing
MSC markers CD73, CD90 and CD105 were reported to be enriched in head and neck squamous
cell carcinoma [10]. MSC-derived factors act on cancer cells to release cytokines, inflammatory
mediators and angiogenic factors, and simultaneously inhibit immune cell function [11]. However,
there are also studies that indicate tumor-suppressing activities of MSCs. He and colleagues reported
that conditioned media from umbilical cord MSCs inhibited breast cancer cell growth, migration
and metastasis [12]. BM-MSCs were reported to inhibit angiogenesis and induce apoptosis [13,14].
Nevertheless, the immunosuppressive function of MSCs in general is not always observed, as it
depends on variables such as the cell dose, proximity to immune cells, and stimulation by inflammatory
cytokines [15]. Given that MSCs are often branded as a promising therapeutic tool, it is necessary to
examine MSCs from different sources and in different contexts to understand their biological functions
and evaluate their clinical prospects better.
Using a 3-dimensional (3D) myoma organotypic invasion model, we have previously investigated
the interaction of BM-MSCs with oral tongue squamous cell carcinoma (OTSCC) cell lines, focusing on
the analysis of invasion and gene expression profiles. Our results demonstrated that BM-MSCs were
able to promote the invasion of OTSCC cells via inducing the expression of genes linked to chemokine
signaling, epithelial plasticity, cell motility and invasion [16].
In this study, we first analyzed the effect of conditioned media from AT-MSCs and BM-MSCs on
global long interspersed element-1 (LINE-1) methylation levels in human tongue squamous carcinoma
(HSC-3) cells, and the same for HSC-3-derived conditioned media on AT-MSCs and BM-MSCs (Figure 1).
LINE-1 is a repetitive DNA element comprising nearly a fifth of the human genome and its methylation
level may reflect global genomic methylation [17]. Global LINE-1 methylation has been observed
to precede tumor development and may serve as an early indicator of cancer [18]. In parallel, we
analyzed changes in expression of intercellular adhesion molecule 1 (ICAM1), integrin alpha-3 (ITGA3)
and matrix metallopeptidase 1 (MMP1) expression in AT-MSCs, BM-MSCs and HSC-3 cells in this
bidirectional study. ICAM1, ITGA3 and MMP1 are involved in the remodeling of the extracellular
matrix, and their expression is known to be aberrant in some cancers [19–21]. We also examined the
tumorigenic potential of AT-MSCs on OTSCC by evaluating the proliferation, migration and invasion
of HSC-3 and dysplastic oral keratinocyte (DOK) cells.
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Figure 1. Study design workflow. Adipose tissue-derived mesenchymal stem cells (AT-MSCs) and
bone marrow-derived mesenchymal stem cells (BM-MSCs) were first characterized and then used for
conditioned media studies with human tongue squamous carcinoma (HSC-3) cells. Cells growing
in conditioned media were analyzed for long interspersed nuclear element-1 (LINE-1) methylation
and changes in expression of microenvironment remodeling genes. AT-MSCs, HSC-3 cells, dysplastic
oral keratinocyte (DOK) cells, and normal oral fibroblasts (NOFs) were used in a co-culture system for
invasion, proliferation and migration studies.
2. Results
2.1. HSC-3- and MSCs-Conditioned Media had no Effect on LINE-1 Methylation
In order to evaluate whether the methylation profile of HSC-3 cells could be affected by contents of
the secretome (in conditioned media) from AT-MSCs and BM-MSCs, methylation analysis on a specific
site of the LINE-1 element was performed. While the methylation-specific multiplex ligation-dependent
probe amplification (MS-MLPA) assay used here includes three methylated sites in LINE-1, the result
here was based on the site that is used in most LINE-1 methylation assays. HSC-3 cells were grown in
conditioned media from AT-MSCs (n= 2) and BM-MSCs (n= 2) for four days, following which DNA was
extracted for MS-MLPA. Average LINE-1 methylation in HSC-3 cells grown in both MSCs-conditioned
media was marginally lower than that in HSC-3 cells grown in serum-free media (baseline, Figure 2A).
Though conditioned media were taken from only two donors per MSC type, none of the conditioned
media were indicated to have had any effect on LINE-1 methylation in HSC-3 cells. In the reverse
setup, where AT-MSCs (n = 4) and BM-MSCs (n = 4) were grown in HSC-3-conditioned media for four
days, the average LINE-1 methylation level in both MSC types grown in HSC-3-conditioned media
was comparable to baseline LINE-1 methylation, based on cells grown in serum-free media (Figure 2B).
2.2. Microenvironment Remodeling genes Expression of HSC-3 and MSCs Cells were Mainly Unaffected when
Cultured in MSCs- or HSC-3-Conditioned Media
We then investigated whether conditioned media from AT-MSCs and BM-MSCs could affect
the expression of genes involved in the microenvironment remodeling of HSC-3 cells. HSC-3 cells
were grown in conditioned media from AT-MSCs (n = 2) and BM-MSCs (n = 2) for four days and
evaluated for the expression of ICAM1, ITGA3 and MMP1 by quantitative real-time PCR (qRT-PCR)
(Figure 3; Supplementary Table S1). ICAM1 and ITGA3 expression in HSC-3 cells growing in both types
of MSCs-conditioned media was comparable to that of cells growing in serum-free media (control).
Int. J. Mol. Sci. 2020, 21, 6455 4 of 15
MMP1 expression was slightly higher in HSC-3 cells when grown in AT-MSC and BM-MSC media
(around 1.5- and 2.5-fold, respectively) compared to the control.Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 4 of 15 
 
 
Figure 2. Effect of HSC-3- and mesenchymal stem cells (MSCs)-conditioned media on LINE-1 
methylation in target cells. (A) HSC-3 cells were grown in (AT- and BM-) MSCs-derived conditioned 
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multiplex ligation-dependent probe amplification (MS-MLPA). The dashed line, baseline 
methylation, is based on HSC-3 cells grown in serum-free media. (B) AT-MSCs (olive green) and BM-
MSCs (red) were grown in HSC-3-derived conditioned media. DNA was isolated from cells and 
LINE-1 methylation was analyzed by MS-MLPA. Dashed lines represent baseline methylation for 
each cell type, based on MSCs growing in serum-free media. 
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Figure 2. Effect of HSC-3- and mesenchymal stem cells (MSCs)-conditioned media on LINE-1
methylation in target cells. (A) HSC-3 cells were grown in (AT- and BM-) MSCs-derived c ditioned
edia. DNA was isolated from cells and LINE-1 methylation was analyzed by methylation-specific
ultiplex ligation-dependent probe amplification (MS-MLPA). The dashed line, baseline methylation,
is based on HSC-3 cells grown in serum-free media. (B) AT- SCs (olive green) and BM-MSCs (red) were
grown in HSC-3-derived conditioned media. DNA was isolated from cells and LINE-1 methylation
was analyzed by MS-MLPA. Dashed lines represent baseline methylation for each cell type, based on
MSCs growing in serum-free media.
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Figure 3. ICAM1, ITGA3 and MMP1 gene expression of HSC-3 and MSCs cells were mainly unaffected 
when cultured in MSCs- or HSC-3-conditioned media. HSC-3 cells were grown in (AT- and BM-) 
MSCs-derived conditioned media (A), while AT-MSCs and BM-MSCs were grown in HSC-3-derived 
conditioned media (B). RNA was isolated from cells and reverse-transcribed to cDNA, then analyzed 
for changes in gene expression of ICAM1, ITGA3 and MMP1. Fold-change values were normalized to 
expression levels of the same cells grown in serum-free media. 
2.3. AT-MSCs had no Effect on the Invasion and the Proliferation Abilities of HSC-3 or DOK Cells 
Since BM-MSCs were previously shown to induce oral cancer growth, we investigated if AT-
MSCs have similar effects. We co-cultured HSC-3 and DOK cells with AT-MSCs and normal oral 
Figure 3. ICAM1, ITGA3 and MMP1 gene expression of HSC-3 and MSCs cells were mainly unaffected
when cultured in MSCs- or HSC-3-conditioned media. HSC-3 cells were grown in (AT- and BM-)
MSCs-derived conditioned media (A), while AT- SCs and B -MSCs were grown in HSC-3-derived
conditioned media (B). RNA was isolated fro ls and r v rse-transcribed to cDNA, then analyzed
for changes in gene expression of ICAM1, ITG 3 and MP1. Fold-change values were normalized to
expression levels of the same cells grown in serum-free media.
In a similar way, AT-MSCs (n = 2) and BM-MSCs (n = 2) were grown in HSC-3-derived conditioned
media for four days, and expression levels of the same genes were analyzed (Figure 3B; Supplementary
Table S2). Here, only ITGA3 expression was comparable to the control. ICAM1 levels were 14- and
5-fold higher in AT-MSCs and BM-MSCs, respectively, whereas MMP1 levels were higher by 6- to
60-fold in both cell types.
2.3. AT-MSCs had no Effect on the Invasion and the Proliferation Abilities of HSC-3 or DOK Cells
Since BM-MSCs were previously shown to induce oral cancer growth, we investigated if AT-MSCs
have similar effects. We co-cultured HSC-3 and DOK cells with AT-MSCs and normal oral fibroblasts
(NOFs) as the positive control using a 3D myoma disc organotypic model. Both the invasion area and
depth were measured using ImageJ software based on pan-cytokeratin staining. Neither the invasion
area nor the depth of invasion of HSC-3 and DOK cells were affected by adding AT-MSCs. On the
other hand, NOFs, as a control, increased the invasion area and the depth of both HSC-3 and DOK.
The increase in the invasion surface area reached statistical significance (Figure 4). Similarly, the number
of the small tumor cell islands, budding, was increased when NOFs were added (Figure 4F,G).
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Figure 4. Invasion of DOK and HSC-3 cells was not affected by the presence of AT-MSCs. (A) Representative
pictures of the pan-cytokeratin-stained cells in the myoma discs, pictures were taken at magnification
4×. DOK (B,D,F) and HSC-3 (C,E,G) cells were co-cultured with AT-MSCs and NOF using myoma
organotypic model. Cells’ invasion and their ability to form budding were studied.
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To investigate if AT-MSCs have an effect on cancer cells’ proliferation, myoma samples were
stained with Ki67 and the percentage of the positive cells was calculated. Neither AT-MSCs nor NOFs
increased the proliferation ability of the cancer cells (Figure 5).
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2.4. AT-MSCs and NOF did not Increase the Migration of HSC-3/DOK Cells 
As cancer cells migration is an important feature for cancer progression, we used an IncuCyte 
wound healing migration assay to study the effect of AT-MSCs and NOFs on the cancer and 
dysplastic cells migration ability. HSC-3 and DOK were co-cultured with AT-MSCs and NOFs, and 
a wound was made using a WoundMaker™ tool. The wound closure rate was monitored for 24 h. 
Neither AT-MSCs nor NOFs increased, but rather decreased, the migration of HSC-3 and DOK cells 
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Figure 5. Proliferation of DOK and HSC-3 was not affected by the presence of AT-MSCs. (A) DOK and
HSC-3 cells were co-cultured with AT-MSCs and NOF using a myoma organotypic model, pictures
were taken at magnification 10×. (B,C) Ki67 was used as a marker for cell proliferation.
2.4. AT-MSCs and NOF did not Increase the Migration of HSC-3/DOK Cells
As cancer cells migration is a important feature for cancer progr s ion, we used an IncuCyte
wound healing migration assay to study the effect of AT-MSCs and NOFs on the cancer and dysplastic
cells migration ability. HSC-3 and DOK were co-cultured with AT-MSCs and NOFs, and a wound was
made using a WoundMaker™ tool. The wound closure rate was monitored for 24 h. Neither AT-MSCs
nor NOFs increased, but rather decreased, the migration of HSC-3 and DOK cells (Figure 6).
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3. Discussion
AT-MSCs and BM-MSCs share several biological features but also have a considerable number of
differences altogether, therefore they are expected to differ in their functional effects. Initially, differences
in their operational features, such as frequency in isolated tissue, ease of harvest, differentiation potential
and proliferative capacity, may be considered for their use in a clinical context. Yet, differences in
their behavior in tissue and in vivo environments require greater attention. Overall functions of
MSCs include regulation of tissue homeostasis and support of tissue integrity. In general, MSCs
have an innate tendency to migrate towards damaged tissue and wounds to promote regenerative
activities [22,23].
ith regard to cancer, it is known that tumor-derived cytokines and other soluble factors
attract MSCs towards the tumor microenvironment, thereby playing a vital role in determining the
tumor fate [24]. Tumor-associated MSCs have the ability to modulate the tumor microenvironment,
since they can exert either stimulatory or inhibitory effects on tumor pathology [6]. For example,
conditioned media from AT- SC reduced the metabolic activity and viability of renal and bladder
carcinoma, but also increased the cancer cells’ resistance to chemotherapy [25]. Effects of MSCs
are also context-dependent: one study reported anti-tumor effects of BM-MSCs on lung cancer and
esophageal cancer in vitro, yet they were found to enhance tumor growth in vivo in the same study [26].
With current evidence suggesting that AT-MSCs and BM-MSCs show both anti- and pro-tumor effects
in various cancers, this dual function of MSCs could be influenced by several factors, such as: MSCs
origin and source, cancer type and the secretome of MSCs and its interaction with the host immune
system and other cells in the tumor microenvironment.
Our findings showed that conditioned media from both AT- SCs and B - SCs had very
subtle effects on the LINE-1 methylation of HSC-3 cells, and the same when AT- SCs and B - SCs
were grown in conditioned media derived from HSC-3. Hypomethylation of LINE-1 is a common
phenomenon in many cancers [27], and was also observed in one of our recent studies where AT-MSCs
were treated with osteosarcoma-derived extracellular vesicles (EVs) [28]. Those EVs were found to
influence AT-MSCs at both the genetic and epigenetic level. In this study, however, no significant
changes in methylation level were observed with the conditioned media.
The conditioned media from HSC-3 cells induced upregulation of ICAM1 and MMP1 in both AT-
and BM- MSCs. ICAM1 expression was upregulated to a higher degree in AT-MSCs than in BM-MSCs,
while MMP1 had comparable levels of upregulation in both AT- and BM-MSCs. ICA 1 facilitates
intercellular interactions between cells and is implicated in promoting the invasiveness and metastatic
ability of cancers [29,30]. Meanwhile, MP1 has been shown to be necessary for the migration of
BM-MSCs toward gliomas [31]. MMP1 and other matrix metalloproteinases (MMPs) are upregulated
in OTSCC and promote invasion [32,33]. Lastly, no changes in ITGA3 expression were observed in any
of the cells, though it has been reported to be over-expressed in many cancers [20]. Though normal
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MSCs did not affect gene expression or LINE-1 methylation in HSC-3 cells, it is possible that MSCs
conditioned with HSC-3 media may have pro-tumor effects on HSC-3 cells.
Proliferation, migration, invasion and budding formation are important features needed for cancer
progression. AT-MSCs have previously been reported to promote proliferation, invasion and MMPs
secretion in epithelial ovarian cancer [34]. Additionally, we have reported that BM-MSCs reduced the
proliferation and enhanced the invasion of OTSCC [16]. In this study, however, we were not able to
detect similar effects of AT-MSCs on HSC-3 and DOK cells. Conditioned media from AT-MSCs also
had minimal effects on MMP1 expression in HSC-3 cells. This clearly shows the differences in the
behavior of MSCs based on their origin and the target cells. These results point out that in contrast to
BM-MSCs, AT-MSCs do not enhance the aggressiveness of oral dysplastic and cancer cells in vitro.
MSCs offer much promise in regenerative medicine, yet the controversies surrounding the
functional effects in vivo and safety concerns hinder their widespread approval. At the moment,
AT-MSCs are not as popular as BM-MSCs for therapeutic applications, but their relatively easier
harvesting procedures and greater yield from tissues are attractive features that have contributed
to a growing interest in AT-MSCs. Nevertheless, functional and clinical studies are of essence to
determine the safety and efficiency of AT-MSCs, before they can be established as a viable alternative to
BM-MSCs. Furthermore, donor-linked features introduce heterogeneities in MSC behavior, therefore
quality control assessments would be necessary to deem them fit-for-purpose. This study indicated
that AT-MSCs do not enhance the invasive or migratory potential of OTSCC cells, nor do they influence
the expression of microenvironment-remodeling genes in OTSCC. Hence, AT-MSCs are suggested to
be more benign than BM-MSCs against OTSCC, with previous findings in consideration. However,
this study consisted of a limited number of samples and in vitro investigations, with only OTSCC
cells as a target. Analyses of other functional effects and long-term monitoring of in vivo studies are
required before making a case for the use of AT-MSCs in clinical applications.
4. Materials and Methods
4.1. Cell Cultures
Human AT-MSCs were derived from surplus adipose tissue received from plastic surgery
procedures at the Department of Plastic Surgery (Laser Tilkka Ltd., Helsinki, Finland). The study was
carried out under approval of the ethical committee of Helsinki and Uusimaa Hospital District and
with informed consent from the donors (Ethical approval DNro: 217/13/03/02/2015 and HUS/3061/2019).
AT-MSCs were obtained from liposuction aspirates from donors using mechanical and enzymatic
isolation as described previously [35]. All donors were female, age range 37–54 years, average
46.4 years; body mass index (BMI) range 24–32 kg/m2, average 26.7 kg/m2. Cells were cultured in
AT-MSCs media consisting of Dulbecco’s modified Eagle’s medium (DMEM)/Ham’s Nutrient Mixture
F-12 with 1% L-alanyl-L-glutamine (DMEM/F-12 1:1 GlutaMAX; Gibco, Paisley, UK), 1% antibiotics
(100 U/mL penicillin, 0.1 mg/mL streptomycin; Lonza, Verviers, Belgium) and 10% Fetal Bovine Serum
(FBS, South American, Gibco). Cells were grown at +37 ◦C with 5% CO2 and under humid conditions.
In this study, AT-MSCs were in passage 2–6. Once AT-MSCs adhered to the culture flask surface,
non-adherent populations were washed away with PBS, and fresh media were added.
Human BM-MSCs were received as a kind gift from Assoc. Prof. Susanna Miettinen (University
of Tampere, Tampere, Finland). Donors consisted of three male and one female; age range 69–92,
average 84.5; BMI range 19–29, average 24.7. These cells were cultured similarly to AT-MSCs. Cells
were in passage 3–4.
HSC-3 cells (Japan Health Sciences Foundation, Tokyo, Japan) cells and DOK (Sigma-Aldrich,
St. Louis, MO, USA) were cultured using DMEM/F-12 (Gibco) supplied with 10% heat-inactivated FBS,
100 U/mL penicillin, 100 µg/mL streptomycin, 50 µg/mL ascorbic acid and 250 ng/mL fungizone (all
from Sigma-Aldrich). NOFs were established from tissue explants as described previously [36] and
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cultured using DMEM supplemented with 10% FBS, 100 U/mL penicillin, 100 µg/mL streptomycin,
250 ng/mL fungizone, 1% sodium pyruvate (Sigma-Aldrich) and 50 µg/mL ascorbic acid.
4.2. MSCs Characterization
The MSCs were characterized according to the International Society Cell & Gene Therapy (ISCT)
guidelines, i.e., plastic-adherence, specific surface marker expression and multipotent differentiation
potential [37]. The multipotentiality of these cells has been reported in our previous papers [38,39].
AT-MSCs (n = 5) and BM-MSCs (n = 4) were characterized using a BD Accuri C6 flow cytometer
(Becton Dickinson, Franklin Lakes, NJ, USA) to confirm the mesenchymal origin of the cells (Table 1).
Allophycocyanin-conjugated monoclonal antibodies against CD14, CD19, CD34, CD45RO, CD54,
CD73, CD90, CD105 and HLA-DR (Becton Dickinson) were used to stain at least 100,000 cells per
antibody. Analysis was performed for 10,000 events with positive expression defined as the level of
fluorescence greater than 99% of the corresponding unstained cell sample.
Table 1. Characterization of AT-MSCs and BM-MSCs by surface marker expression with flow cytometry
analysis. Clone information for marker antibodies is also provided.
Marker Clone
% Expression in Cells
(Average ± Standard Deviation)
AT-MSC (n = 5) BM-MSC (n = 4)
CD14 M5E2 1.7 ± 2.8 0.4 ± 0.3
CD19 HIB19 0.3 ± 0.4 0.3 ± 0.2
CD34 581 31.9 ± 25.4 1.1 ± 1.4
CD45RO UCHL1 1.4 ± 2.3 0.5 ± 0.3
CD54 HA58 61.8 ± 22.8 12.4 ± 2.2
CD73 AD2 99.0 ± 1.8 99.5 ± 0.3
CD90 5E10 99.3 ± 0.7 94.6 ± 5.1
CD105 266 96.1 ± 7.1 98.2 ± 1.0
HLA-DR G46-6 1.7 ± 3.1 1.5 ± 0.8
All nine MSC cell lines were positive for surface markers CD73, CD90 and CD105 in > 90% of
their population, the only exceptions being one AT-MSC cell line with a lower expression of CD105
and one BM-MSC cell line with a slightly lower expression of CD90 (Table 1). MSCs were adherent
and displayed multipotent differentiation. AT-MSCs had higher expression of CD34 and CD54 than
BM-MSCs. Otherwise, both AT- and BM-MSCs had very low expression of CD14, CD19, CD45
and HLA-DR.
4.3. Culture of MSCs and HSC-3 Cells in Conditioned Media
A total of 500,000 cells of each cell type (AT-MSC, BM-MSC and HSC-3) were plated in T-175
flasks (Corning Inc., Corning, NY, USA) and grown until they approached 70% confluency. Then,
the growth media were changed to serum-free conditions (no FBS) and collected after 24 h of culture.
The confluency approach was taken to normalize the metabolite content in the conditioned media.
Conditioned media were centrifuged at 600× g, after which the supernatant was passed through a
0.45 µm filter and stored at −80 ◦C until use. HSC-3 cells were grown for 24 h, then washed with PBS
and grown in (AT- and BM-)MSCs-derived conditioned media for four days. AT-MSC and BM-MSC
cells were grown for 24 h and let to adhere, then washed with PBS and grown in HSC-3-derived
conditioned media for four days. In all cases, the same cells were grown in serum-free media as
a control.
4.4. Gene Expression Analysis with qRT-PCR
Total RNA was extracted from AT-MSCs, BM-MSCs and HSC-3 cells using the NucleoSpin® RNA
isolation kit (Macherey-Nagel, Düren, Germany) and reverse-transcribed to cDNA using SuperScript™
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IV VILO™ Master Mix (Thermo Fisher Scientific Baltics UAB, Vilnius, Lithuania). All qRT-PCR
reactions were conducted in triplicates on MicroAmp™ Optical 96-well reaction plates using TaqMan
assays, with reactions carried out in QuantStudio 5 (all from Life Technologies, Carlsbad, CA, USA).
The expression of the following genes was quantified: intercellular adhesion molecule 1 (ICAM1, assay
ID Hs00164932_m1), integrin alpha-3 (ITGA3, assay ID Hs01076879_m1) and matrix metallopeptidase
1 (MMP1, assay ID Hs00899658_m1). Expression levels were normalized with the housekeeping gene,
ribosomal protein lateral stalk subunit P0 (RPLP0, assay ID Hs99999902_m1), and calculated using the
ddCt-method [40].
4.5. LINE-1 Methylation Analysis
DNA was extracted from AT-MSCs, BM-MSCs and HSC-3 cells using NucleoSpin® Tissue
(Macherey-Nagel). For two samples that had a low cell number, NucleoSpin® Tissue XS
(Macherey-Nagel) was used. A total of 90 ng of DNA was used to perform the MS-MLPA reactions,
using the SALSA MS-MLPA Reagents kit and P300-B1 Human DNA Reference-2 (MRC-Holland,
Amsterdam, The Netherlands). A customized set of LINE-1 probes was used according to a previously
established protocol [41,42]. Two controls were used: one commercially available colon cancer cell line
RKO (ATCC® CRL-2577™, Manassas, VA, USA) and one unmethylated sample generated using the
GenomePlex complete whole genome amplification kit. The methylation dosage ratio was calculated
as described previously [41].
4.6. Organotypic Myoma Discs
In order to study the effect of AT-MSCs on oral cancer (HSC-3) and dysplastic (DOK) cell
proliferation and invasion, we have developed an in vitro model using human uterine leiomyoma
discs [43]. NOFs were used as the positive control. The use of myoma tissue was approved by the
Ethics Committee of Oulu University Hospital, and all patients signed an informed consent form.
We prepared uterine myoma discs and completed invasion experiments with some modifications,
as described previously [43,44]. Briefly, we placed myoma discs into Transwell® inserts (Corning Inc.,
Corning, NY, USA) and 40 × 104 HSC-3 or DOK with or without 20 × 104 AT-MSCs or NOFs seeded
on top of the discs. The cells were allowed to adhere overnight, and on the next day, the discs were
transferred onto a steel grid in a 12-well plate supplied with 1 mL culture media replaced every 3 to
4 days for 10 days. Myoma discs were fixed in 10% formalin and embedded in paraffin blocks.
4.7. Immunohistochemical Staining of the Myoma Discs
Samples were cut into 4-µm-thick sections and stained using a fully automated Leica BOND-MAX
staining robot (Leica Microsystems, Wetzlar, Germany) and a horseradish peroxidase–labeled dextran
polymer method. As for primary antibodies, we used monoclonal mouse anti-human pan-cytokeratin
(0.7 µg/mL) and Ki67 (0.8 µg/mL), both from Dako (Dako, Glostrup, Denmark).
4.8. Scratch-Wound Cell Migration Assay
To test the effect of AT-MSCs and NOFs on HSC-3 and DOK cell migration, wells of a 96-well
Imagelock plate (Essen Bioscience, Ann Arbor, MI, USA) were coated with 300 µg/mL human Myogel
matrix [45] and incubated overnight (37 ◦C). Leftover Myogel was removed by suction and cell
suspensions (100 µL/well) were seeded and left to adhere overnight in an incubator. Cell densities were
optimized to achieve a confluent cell layer after 24 h; HSC-3 (25,000 cells/well), NOFs (12,500 cells/well),
AT-MSCs (12,500 cells/well) and DOK (20,000 cells/well). Cell lines were seeded alone and as a mixture
of two cell lines. For preparation of homogeneous wounds, we used a WoundMaker™ tool (Essen
Bioscience). After wound making, cell culture media were replaced with 100 µL of fresh media. Wound
confluence was monitored using the IncuCyte Zoom Live-Cell Imaging System (Essen Bioscience) by
taking images every second hour for 24 h.
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4.9. Microscopic and Histomorphometric Analysis
Slides were imaged using a Leica DM6000 B/M light microscope connected to a digital camera
(DFC420; Leica Microsystems). We used ImageJ 1.51 (64-bit) software to measure the invasion area,
the invasion depth and the average cell island size, budding, as described previously [43,44,46].
The percentage of Ki67+ cells was calculated from at least three randomly selected fields of the
non-invading cells (on the myoma surface).
4.10. Statistical Analysis
When characterizing MSCs from different donors in terms of surface marker expression, values
were reported as means ± standard deviations. Gene expression values were also provided as
means ± standard deviations. Myoma invasion experiments were repeated four times independently,
each in duplicate. Values are given as means ± standard deviations. To determine the statistical
significance, we performed one-way analysis of variance (ANOVA) followed by the Bonferroni post
hoc test. We set statistical significance to P < 0.05.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/18/
6455/s1.
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ANOVA Analysis of variance
AT-MSC Adipose tissue-derived mesenchymal stem cell
BM-MSC Bone marrow-derived mesenchymal stem cell
DOK Dysplastic oral keratinocyte
EV Extracellular vesicle
HSC-3 Human tongue squamous carcinoma
ICAM1 Intercellular adhesion molecule-1
ITGA3 Integrin alpha-3
LINE-1 Long interspersed nuclear element-1
MMP Matrix metallopeptidase
MSC Mesenchymal stem cell
MS-MLPA Multiplex ligation-dependent probe amplification
NOF Normal oral fibroblast
OTSCC Oral tongue squamous cell carcinoma
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